Spectral Camera
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q00404
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6650
Additional Details
Documents1
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a solicitation for the procurement of a portable hyperspectral camera system. This requirement, identified by Procurement Identifier 75F40126Q00404, is managed by the FDA Office of Acquisition and Grant Services and is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6650.
The primary objective of this procurement is to acquire one (1) portable hyperspectral camera, complete with all necessary commercial accessories, software, user documentation, warranty, and technical support to ensure full operational capability. The intended outcome is to enhance the FDA’s analytical and imaging capabilities, supporting its mission in scientific research and regulatory activities.
Key technical requirements for the hyperspectral camera system include:
- Spectral operation across a wavelength range of 400 nm to 800 nm.
- Provision of 200 or more evenly distributed spectral bands.
- Spectral bandwidth (FWHM) of 7 nm or less.
- Image output resolution of at least 512 × 512 pixels.
- Minimum spectral resolution of 12 bits per pixel.
- Focusing capability from approximately 15 centimeters to infinity.
- Standalone operation with an integrated display and user interface, eliminating the need for an external computer during normal use.
- Data storage on portable media for transfer to external computers.
- Operation via an internal rechargeable battery, with charging supported by standard 120V, 60 Hz U.S. power.
- Total system weight not exceeding 2 kilograms.
- Inclusion of a minimum one-year manufacturer’s warranty and technical support.
- Delivery required within six (6) weeks after contract award.
- No on-site installation is required; user documentation must be provided in electronic or hard-copy format.
The place of performance for this procurement is Silver Spring, Maryland, United States. There are no set-aside restrictions for this solicitation, making it open to all qualified vendors. The procurement is being conducted as a standard federal solicitation, and interested parties should note that the opportunity is currently active.
The FDA Office of Acquisition and Grant Services is the contracting entity responsible for this requirement. The primary point of contact for this solicitation is Reagan Davis, who can be reached at [email protected] or by phone at 301-796-0910.
Contractors interested in this opportunity should ensure their proposed solutions meet all specified technical and operational requirements and are capable of delivering the complete system within the stipulated timeframe. The solicitation and any associated attachments can be accessed via the official SAM.gov opportunity page: https://sam.gov/opp/422314af912840999d45955720f55c6e/view. The response deadline for this notice is September 1, 2026, at 16:09.
This procurement represents a focused investment in advanced imaging technology to support the FDA’s ongoing scientific and regulatory initiatives. Vendors with expertise in analytical laboratory instrument manufacturing and the ability to deliver high-performance hyperspectral imaging solutions are encouraged to review the solicitation in detail and consider submitting a response.